达安基因：历来披露全资及控股子公司获得三类医疗器械注册证的情况

Group 1 - The company disclosed that it has a history of reporting the acquisition of Class III medical device registration certificates by its wholly-owned and controlled subsidiaries [1] - Guangzhou Saiyun Biotechnology Co., Ltd. is a joint venture of the company's controlled subsidiary, Guangzhou Darui Biotechnology Co., Ltd., and is not included in the company's consolidated financial statements [1]